Arrigo Mattia, Ruschitzka Frank, Flammer Andreas J
1 Klinik für Kardiologie, Universitätsspital Zürich.
Ther Umsch. 2018 Sep;75(3):155-160. doi: 10.1024/0040-5930/a000980.
Acute heart failure Abstract. Acute heart failure (AHF) is a life-threatening condition requiring immediate treatment. The initial therapy should take into account the clinical presentation, the pathophysiology at play, the precipitating factors, and the underlying cardiac pathology. Particular attention should be given to polymorbidity and the avoidance of potential iatrogenic harms. Patient preferences and ethical issues should be integrated into the treatment plan at an early stage. The average survival of AHF patients is two years and the most vulnerable period is the three-month time window directly after discharge. Therefore, reducing both persistent subclinical congestion and underutilization of disease-modifying heart failure therapies as well as ensuring optimal transitions of care after hospital discharge are essentials in improving outcomes of AHF patients.
急性心力衰竭 摘要。急性心力衰竭(AHF)是一种危及生命的疾病,需要立即治疗。初始治疗应考虑临床表现、起作用的病理生理学、诱发因素以及潜在的心脏病理学。应特别关注多种疾病并存情况以及避免潜在的医源性伤害。患者偏好和伦理问题应在早期纳入治疗计划。AHF患者的平均生存期为两年,最脆弱的时期是出院后的三个月时间窗。因此,减少持续性亚临床充血和疾病修饰性心力衰竭治疗的未充分利用,以及确保出院后最佳的护理过渡,是改善AHF患者预后的关键。